Checklist S1 - The Effect of Intra-Arterial Angiotensin II on the Hepatic Tumor to Non-Tumor Blood Flow Ratio for Radioembolization: A Systematic Review
To establish a modified strategy of the feeding artery ablation (FAA) procedure as an add-on to percutaneous radiofrequency ablation (RFA) for patients with hypervascular hepatocellular carcinoma (HCC
Note. T0 = baseline. T1 = within the first week after the procedure. T2 = one month after the procedure.μ1 = mean tumoral size at T0 in patients treated with TAELE, in centimeters.μ2 = mean tumoral si
Concurrent reduction in arterial and venous flow after with MHT treatment which contributed to decreased half-life AVTT. Tabulated data represents average of ∼30 ROIs per treatment group (n = 5) where
